Reporting by pharma companies on spending on physicians is becoming a non-event
Compared to 2014, when the Physician Sunshine Act rules first went into place, and the first public airing of the aggregated data appeared at CMS in September, this year’s reporting cycle appears to be moving along almost without a hitch. Under the Sunshine Act, manufacturers are obligated to report spending on physicians and certain other healthcare providers, for the 2014 calendar year, by March 31. Comparable rules, with different reporting requirements, also exist in the EU.
Cegedim Relationship Management (Bedminster, NJ), which says it has 60 leading pharma companies worldwide using its AggregateSpend360 software package, announced an update of that package at a recent users group meeting. New features include revised resubmission and validation processes for filing with CMS, and a payment-collection and consent-management feature for European reporting.
The users group meeting also gave the company a chance to poll its clients on current agg-spend practices. Among other findings, Cegedim says:
Cegedim has started the surveying for a 2015 industry-wide trend report, which it has published annually for several years now. Industry representatives who want to participate should contact the company.